Bioventus Details Turnaround Plan, Four Growth Drivers at J.P. Morgan Conference [Yahoo! Finance]
Bioventus Inc. - Class A (BVS)
Company Research
Source: Yahoo! Finance
EBITDA expansion and over $100M of operating cash flow in the last two years, while reducing debt to below $300M and leverage to Management will invest disproportionately in four growth drivers — PNS (FDA-cleared Talisman/StimTrial moving from pilot to full launch), PRP (commercial entry late 2024), ultrasonics, and international — funded by core cash flow and evaluated through a strict ROIC lens. Bioventus expects adjusted EPS to grow two-to-three times faster than revenue in 2026, forecasts cash flow to almost double from 2024 to 2025 with further acceleration in 2026, and will prioritize deleveraging over buybacks while only pursuing highly synergistic M&A. Interested in Bioventus Inc.? Here are five stocks we like better. Bioventus (NASDAQ:BVS) executives outlined a multi-year turnaround story and a set of new growth priorities during a presentation and Q&A session hosted by J.P. Morgan healthcare analyst David Brumund. CEO Rob Claypoole and CFO Mark Singleton emphasized
Show less
Read more
Impact Snapshot
Event Time:
BVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BVS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BVS alerts
High impacting Bioventus Inc. - Class A news events
Weekly update
A roundup of the hottest topics
BVS
News
- Bioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Bioventus to Present at the 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewswire
- HALPER SADEH LLC ENCOURAGES BIOVENTUS INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTSPR Newswire
- Bioventus: A New Start [Seeking Alpha]Seeking Alpha
- Bioventus to Present at the Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]Yahoo! Finance
BVS
Earnings
- 8/6/25 - Miss
BVS
Sec Filings
- 1/13/26 - Form 4
- 12/8/25 - Form 4
- 12/4/25 - Form 144
- BVS's page on the SEC website